Literature DB >> 9613295

Clinical utility of EEG parameters to predict loss of consciousness and response to skin incision during total intravenous anaesthesia.

S Schraag1, U Mohl, U Bothner, M Georgieff.   

Abstract

We studied 30 female patients undergoing elective surgery, to assess the reliability of electroencephalogram spectral edge frequency and median frequency to predict loss of consciousness and movement in response to skin incision during total intravenous anaesthesia. Each patient received a different combination of propofol (1, 2, 3, 4, 5 or 6 micrograms.ml-1) and sufentanil (0.1, 0.2, 0.3, 0.5 or 1.0 ng.ml-1) target concentrations for induction of anaesthesia using target controlled infusions, assigned randomly. In a logistic regression model, spectral edge frequency was a significant determinant of both loss of consciousness (p = 0.0006) and movement to skin incision (p = 0.0044), whereas for median frequency no significant prediction model could be established. The probabilities of 50% and 95% no response for spectral edge frequency were 13.4 Hz and 6.8 Hz, respectively. The variability of the data limited the predictive value, so that spectral edge frequency was a poor predictor and median frequency was no predictor of response in the individual patient during total intravenous propofol/sufentanil anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613295     DOI: 10.1046/j.1365-2044.1998.00311.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Bayesian probabilistic network modeling of remifentanil and propofol interaction on wakeup time after closed-loop controlled anesthesia.

Authors:  Ulrich Bothtner; Stewart E Milne; Gavin N C Kenny; Michael Georgieff; Stefan Schraag
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

Review 2.  Anaesthetic interventions for prevention of awareness during surgery.

Authors:  Anthony G Messina; Michael Wang; Marshall J Ward; Chase C Wilker; Brett B Smith; Daniel P Vezina; Nathan Leon Pace
Journal:  Cochrane Database Syst Rev       Date:  2016-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.